BCL2 and B-cell chronic lymphocytic leukemia: As an illustration of the point made, it has been demonstrated via both preclinical and clinical research that G3139 (antisense to bcl2 mRNA’s first six codons) has the ability to dramatically induce apoptosis and diminish chemosensitivity in a variety of malignancies, including CLL [227].